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Maleidrides are a class of bioactive secondary metabolites unique to filamentous fungi, which contain one
or more maleic anhydrides fused to a 7-, 8- or 9- membered carbocycle (named heptadrides, octadrides
and nonadrides respectively). Herein structural and biosynthetic studies on the antifungal octadride,
zopfiellin, and nonadrides scytalidin, deoxyscytalidin and castaneiolide are described. A combination of
genome sequencing, bioinformatic analyses, gene disruptions, biotransformations, isotopic feeding
studies, NMR and X-ray crystallography revealed that they share a common biosynthetic pathway,
diverging only after the nonadride deoxyscytalidin. 5-Hydroxylation of deoxyscytalidin occurs prior to
ring contraction in the zopfiellin pathway of Diffractella curvata. In Scytalidium album, 6-hydroxylation –
confirmed as being catalysed by the a-ketoglutarate dependent oxidoreductase ScyL2 – converts
deoxyscytalidin to scytalidin, in the final step in the scytalidin pathway. Feeding scytalidin to a zopfiellin
PKS knockout strain led to the production of the nonadride castaneiolide and two novel ring-open
maleidrides.Introduction
Fungal maleidrides are an important family of polyketide-
derived secondary metabolites which exhibit a diversity of bio-
logical activities including as antifungal1,2 and herbicidal3,4
agents.5 They are characterised by a medium-sized alicyclic ring
with one or two fused maleic anhydride moieties. The majority
of the reported maleidrides are nonadrides assembled on a 9-
membered ring core, and early examples include byssochlamic
acid 1,6 heveadride 2,7 glauconic acid 3 and glaucanic acid 4
(Fig. 1).8,9 Later studies revealed further nonadrides such as the
phomoidrides, e.g. 5,10 castaneiolide 6,11 rubratoxins, e.g. 7 12
and cornexistin 8,3,13 the octadride viburspiran 9 and more
recently two heptadrides agnestadrides A 10 and B have been
isolated from Byssochlamys fulva.14 In certain cases the relative, Cantock's Close, Bristol, BS8 1TS, UK.
iley@bristol.ac.uk; kd4495@bristol.ac.uk
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WZ, Leibniz University of Hannover,
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ESI) available. CCDC 2011262–2011264.
7 and 18. GenBank accession numbers;
4050 (scytalidin BGC). For ESI and
ther electronic format see DOI:
of Chemistry 2020and absolute stereochemistry of the maleidrides remain
unknown, and various details of their biosynthesis are yet to be
fully elucidated.
Results of extensive studies on selected nonadrides using
isotopic labelling, gene knock outs and heterologous expression
experiments have led to the proposal that the biosynthetic
pathway begins with the assembly of an unsaturated precursor 11Fig. 1 Examples of maleidrides.
Chem. Sci.
Scheme 1 The universal pathway to maleidrides16 involves the production of maleic anhydride monomers (A) followed by dimerisation (B) – the
mode of which determines the carbon framework of the final compound.
Fig. 2 Confirmed structures of the natural products 15, 16 and 17.
Fig. 3 Incorporation patterns in octadrides and nonadrides from
feeding studies with [1,2-13C2]-acetate.


























































































View Article Onlinevia an iterative highly reducing polyketide synthase (hrPKS),
where the chain length varies according to the structure of the
natural product (Scheme 1). Coupling of 11 with oxaloacetate isChem. Sci.catalysed by citrate synthase-like enzymes and is followed by
dehydration catalysed by 2-methylcitrate dehydratases to generate
the maleidride monomer 12.15,16 Decarboxylation of 12 then gives
the tautomeric compounds 13 and 14 (Scheme 1A).14,17 The second
stage of the biosynthetic pathway, coupling the monomers in
various modes and cyclisation to the carbocyclic ring, involves
ketosteroid isomerase-like (KSI) and phosphatidylethanolamine
binding protein-like (PEBP) enzymes.16 The mode of cyclisation
determines the carbon framework of the maleidride (Scheme 1B),
and nally tailoring modications decorate these structures
leading to the observed diversity of natural products.
Octadrides, with 8-membered rings, are less common than
nonadrides and include viburspiran 9 18 and zopellin 15 19
(Fig. 1 and 2). The biosynthetic origin of the 8-membered ring is
unknown (§see footnote). Zopellin was rst isolated from
Zopella curvata and the structure determined by a combination
of spectroscopic methods.19–21 The relative and absolute
congurations of zopellin have been indicated in several
publications,22–24 but we were unable to nd any justication of
the conguration of the side chain secondary alcohol. Hence,
with our continuing interest in the biosynthesis of fungal
natural products, and in particular bioactive maleidrides, our
goal was to conrm the structure of zopellin 15 and determine
the biosynthetic origin of the 8-membered ring, with the longer-
term goal of engineering the pathway to new antifungal targets.
Whilst this manuscript was in preparation Minami, Oikawa
and co-workers reported investigations into the biosynthesis of
zopellin using isotopic labelling, heterologous expression of
candidate genes in Aspergillus oryzae, combined with structure
elucidation of minor metabolites. These studies showed that
a ring contraction occurs from a nonadride to an octadride.25
Herein we describe our recent studies which conrm the
absolute and relative congurations of the nonadride scytalidin
16 and octadride zopellin 15 and reveal that they shareThis journal is © The Royal Society of Chemistry 2020
Fig. 4 (A) RNAseq data mapped to the zopfiellin BGC showing coregulation of the genes under four different conditions (Fig. S1 and S2†). Pink:
GN. Purple: CDB. Green: PDB-day 5. Black: PDB-day 8. (B) The zopfiellin gene cluster, as annotated in Artemis, which contains genes zopL9 to
zopR4. (C) The scytalidin gene cluster, as annotated in Artemis, which contains genes scyL2 to scyR12. ‘L’ in the gene names denotes genes to the
left, or upstream, of the PKS. ‘R’ denotes genes to the right, or downstream, of the PKS. Putative gene functions are shown in Table 1.


























































































View Article Onlinea common biosynthetic precursor, deoxyscytalidin 17 (Fig. 2).
Our biosynthetic investigations involved a different approach
from those previously reported25 and used a combination of
gene disruptions in Diffractella curvata and Scytalidium album,
feeding studies to mutant strains and full structure elucidation
of known and novel compounds. These studies establish the
biosynthetic relationships between zopellin 15, scytalidin 16,
and deoxyscytalidin 17.Results and discussion
The conrmed zopellin producer, Zopella curvata no. 37-3,
was not publicly available when these studies began, soTable 1 Predicted functions for genes in the zopfiellin and scytalidin BG
Swissprot database and identifying conserved protein domains using Int
identification homologues within NCBIs non-redundant database. See T
Gene Putative function Homo
zopL9 Hydroxylase/Desaturase DES34
AsaB3
zopL8 Hypothetical protein —
zopL7 Transcription factor (TF) AlnR3
zopL6 Major facilitator superfamily (MFS) transporter Itp1 4
zopL5 2-Methylcitrate dehydratase (2MCDH) PrpD4
zopL4* Ketosteroid isomerase-like protein (KSI) BfL6 1
zopL3 Major facilitator superfamily (MFS) transporter Itp1 4
zopL2 Isochorismatase-like hydrolase/amidohydrolase NicF46
zopL1 Phosphatidylethanolamine-binding protein (PEBP) T1 47
zopPKS hrPKS Tox1-P
zopR1 DUF341 hydrolase/esterase Fub4
zopR2 Enoyl-CoA hydratase Ech1
zopR3 Citrate synthase CshA4
zopR4 FAD-dependent oxidoreductase YanF5
Sol5 5
This journal is © The Royal Society of Chemistry 2020Diffractella curvata CBS591.74 was obtained and conrmed to
produce zopellin. Cultures were grown in shake asks in PDB
medium at 25 C for 14 days and aer purication by ash
chromatography, gave zopellin 15 (80–100mg L1) as an oil. As
full assignment of NMR data had not previously been re-
ported19,21 2D NMR data (COSY, HSQC and HMBC) analysis
allowed assignment of the 1H and 13C NMR spectra (Table S6
and Fig. S31–S36†). The optical rotation, [a]D 84.3 (c 0.43
MeOH) was consistent with the literature value, [a]D 76.8 (c
0.42 MeOH).20 Zopellin was esteried to give the novel p-
nitrobenzoate 18 and X-ray crystallography revealed the relative
conguration of the natural product (Fig. 2). Synthesis and
analysis of the (R)- and (S)-Mosher's ester derivatives of 15Cs. Function were determined by searching for homologues within the
erPro.33 Only the functions of genes marked ‘*’ were assigned via the
ables S1 and S2 for further details
logue Gene Putative function Homologue
scyL2 Hydroxylase AclN36
5 MfR1 37
scyL1* PEBP BfL5 16
8 scyPKS hrPKS Tox1-PKS39
0 scyR1 DUF341 hydrolase/esterase Fub4 41
2 scyR2 Enoyl CoA hydratase Ech1 43
6 scyR3 Citrate synthase MfR3 44
0 scyR4 Isochorismatase-like hydrolase/
amidohydrolase
CSHase45
scyR5 MFS transporter MfM6 44
scyR6* KSI BfL6 16
scyR7 2-Methylcitrate dehydratase PrpD42
KS39 scyR8 Transcription factor AlnR38
41 scyR9 Histone H2A H2A.Z 48
43 scyR10 MFS transporter MfR5 44
9 scyR11 Hypothetical protein —
0 scyR12* PEBP BfL9 16
1,52
Chem. Sci.
Fig. 5 HPLC (DAD) analysis of gene deletion strains for the zopfiellin
and scytalidin gene clusters. Disruption of zopPKS and scyPKS abol-
ished maleidride production in both species, confirming the identity of
the zopfiellin and scytalidin BGCs. Disruption of scyL2 confirmed its
role in the final hydroxylation of the scytalidin pathway.
Fig. 6 An ACT (Artemis Comparison Tool) comparison of the zopfiellin
and scytalidin BGCs identified genes predicted to encode homologous
proteins and highlighted the similarity between the two biosynthetic
gene clusters.


























































































View Article Onlineconrmed the absolute stereochemistry of zopellin as 1R, 5R,
100R (Fig. S81–S83†).
Feeding [1,2-13C2]-acetate to cultures of D. curvata showed
mainly intact incorporation of acetate into zopellin 15 (Fig. 3).
Enhancement of C-5 in the 13C NMR spectrum was observed,
but there was no coupling to an adjacent 13C, indicating that it
originates from a cleaved acetate and therefore that a carbon
atom is lost during zopellin biosynthesis.Chem. Sci.A possible biosynthetic precursor to zopellin is therefore
a nonadride which on rearrangement with the loss of one
carbon atom would give the corresponding octadride. Such ring
contractions are well precedented in fungal biosynthesis, for
example, in the contraction of ring B of the kaurenoids to the
gibberellins,26 the conversion of the 14-membered polyketide
macrodiolide colletotriene to the 13-membered ring of barta-
nol27 and the oxidative ring contractions seen in xenovulene
biosynthesis.28 Conceivably the known natural products scyta-
lidin 16 29 (C22H28O7), deoxyscytalidin 17 30 (C22H28O6) or cas-
taneiolide 6 11 (C22H28O8) could be precursors. To obtain
samples of 16 and 17, cultures of S. album strain UAMH 3620
were grown, and aer 14 days compounds 16 and 17 were iso-
lated in similar titres (ca. 10 mg L1). X-ray analysis conrmed
that the alkyl side chains are syn in both metabolites (Fig. 2).
The results of feeding studies using [1,2-13C2] acetate to cultures
of S. album were in accord with the predicted biosynthetic
pathway to nonadrides and that one or both could possibly be
biosynthetic precursors of zopellin 15 (Fig. 3).
De novo genome sequencing was performed for D. curvata
CBS591.74 and S. album UAMH3620, and an initial screen of the
genome data, searching for homologues to the byssochlamic
acid biosynthetic gene cluster (BGC),16 revealed putative mal-
eidride gene clusters within both genomes. The gene clusters
were analysed in detail using FGeneSH31 to predict coding
sequences, and manually annotated in Artemis32 to produce full
dra BGCs (Fig. 4 and Table 1). Putative gene functions were
assigned via the identication of homologues in the NCBI
database and the detection of conserved domains using Inter-
Pro33 (Tables S1 and S2†). Transcriptomic analysis for D. curvata
under a range of zopellin 15 production and non-production
conditions aided identication of the cluster boundaries by
clearly identifying a co-transcribed region that includes genes
from zopL9 to zopR4 (Fig. 4, S1 and S2†). In addition, detailed
analysis of the transcriptomic data conrmed the positions of
all introns and exons in the predicted ORFs. However, despite
repeated attempts, it was not possible to generate quality
RNAseq data for the putative scytalidin gene cluster in S. album.
To conrm the identity of the two gene clusters, protoplast-
mediated transformation protocols were developed for both
fungal species and the PKS genes; zopPKS and scyPKS, were
disrupted using the bipartite gene knock-out approach devel-
oped by Nielsen et al.53 In both cases this led to a total loss of
maleidride biosynthesis, with no scytalidin 16 or deoxy-
scytalidin 17 being present in the crude extracts of the DscyPKS
strains (Fig. 5e), and no zopellin 15 being present in the crude
extracts of the DzopPKS strains (Fig. 5h).
An ACT (Artemis Comparison Tool)54 comparison of the
zopellin and scytalidin BGCs (Fig. 6) highlighted signicant
homologies. Both clusters contain genes encoding the essential
hrPKS, DUF341 hydrolase, citrate synthase (CS) and 2-methyl-
citrate dehydratase (2MCDH),12,13,15,16 as well as the ‘dimerisa-
tion’ genes encoding a ketosteroid-isomerase-like protein (KSI)
and a PEBP-like protein.16 In the case of the scytalidin BGC
a second PEBP gene is present, which has been observed
previously in the byssochlamic acid and rubratoxin BGCs.12,16 A
domain analysis of the two PKS genes identied all of theThis journal is © The Royal Society of Chemistry 2020
Scheme 2 Feeding studies to D. curvata strain DzopPKS identified 17 and 19 as intermediates in zopfiellin biosynthesis and scytalidin was
metabolised to novel products.
Fig. 7 HPLC (DAD) chromatograms of crude extracts. Feeding
compounds to D. curvata DzopPKS indicate that deoxyscytalidin 17
and 5-hydroxy-deoxyscytalidin 19 are intermediates in the zopfiellin
biosynthetic pathway, whereas scytalidin 16 is not. Feeding of 16 led to
the production of castaneiolide 6 and two novel ring-open anhydrides
20 and 21.


























































































View Article Onlinedomains typically present in a highly-reducing PKS: KS, AT, DH,
CMeT, ER, KR and ACP. Additional genes identied in both
clusters encode an enoyl-CoA hydratase, an isochorismatase,
a small hypothetical protein (zopL8 and scyR11), a GAL4 type
transcription factor and two MFS (major facilitator superfamily)
transporters. The enoyl-CoA hydratase encoded by the zopellin
cluster (zopR2) was not identied in the work by Oikawa and
colleagues,25 but RNAseq data conrmed its annotation.
The proteins encoded by the clusters also have high
sequence identity (Table S3†). The KSI and PEBP-like proteins,
for example, are far more similar to one another (80.7% and
66.2% identity respectively, Table S3†) than to those identied
in other maleidride BGCs (Fig. S4–S7†). In the case of theThis journal is © The Royal Society of Chemistry 2020transporters, ZopL6 and ScyR5 are highly homologous (80.4%
identity) and thus may be expected to transport similar
compounds. The other two transporters, ZopL3 and ScyR10, are
more diverse, sharing only 38.5% identity. All other homo-
logues encoded by the gene clusters share over 50% identity,
with many sharing over 80% (Table S3†).
The only proteins which are uniquely encoded by the zop-
ellin gene cluster are a putative hydroxylase/desaturase
(ZopL9), which shares homology with DES from the gibber-
ellin pathway, and an FAD-dependent oxidoreductase (ZopR4).
The scytalidin gene cluster encodes only one unique protein,
a putative hydroxylase (ScyL2). ZopL9 and ScyL2 are both pre-
dicted to be a-ketoglutarate (aKG) dependent enzymes based on
the presence of conserved iron and aKG binding residues
(Fig. S10†), but they were not considered to be homologues due
to the low level of sequence identity (approximately 25% iden-
tity), suggesting that the exact catalytic function is unlikely to be
the same. Also located within the scytalidin BGC is a gene
(scyR9) encoding a highly conserved H2A.F/Z family histone,55
but this is unlikely to play a direct role in scytalidin biosynthesis
(Table S3†).
The striking similarity between the two gene clusters (Fig. 6)
suggests that zopellin 15 and scytalidin 16 have very similar
biosynthetic origins, and that either deoxyscytalidin 17 or scy-
talidin 16may be precursors of zopellin. To test this theory, 16
and 17 were puried from S. album cultures and separately fed
to D. curvata DzopPKS cultures on days 3 and 5 post-inoculation
(5 mg per day per 100 ml of culture). In cultures fed with 17,
zopellin production was restored (Scheme 2 and Fig. 7e),
demonstrating that deoxyscytalidin 17 is a precursor of zop-
ellin. The extent of conversion of deoxyscytalidin to zopellin
varied between individual feeds, presumably due to varying
expression levels for the zopellin BGC. In cultures where the
conversion was partial, the HPLC trace showed a peak for
deoxyscytalidin, as well as a novel compound with a mass of 404
eluting at 16.1 minutes (Fig. 7e). This metabolite was isolated,
and the structure conrmed by NMR spectroscopy to be 5-
hydroxy-deoxyscytalidin 19 (Table S9 and Fig. S44–S49†). TheChem. Sci.
Scheme 3 Proposed biosynthetic pathways of the maleidrides deoxyscytalidin 17, scytalidin 16 and zopfiellin 15.


























































































View Article Onlinesignal assigned to 5-H (at d 4.90) appeared as a broad singlet
and NOE studies were in accord with hydroxylation occurring
on the same face as the butyl side chain at C-6. To determine
whether 19 is a shunt product or an intermediate on the
biosynthetic pathway, it was fed to D. curvata DzopPKS cultures
and again this restored zopellin biosynthesis (Scheme 2 and
Fig. 7f).
When scytalidin 16 was fed to cultures of D. curvata DzopPKS,
no zopellin was detected, but several additional compounds
were present when compared to controls (Fig. 7g). The mixture
was puried by HPLC giving the known11 nonadride casta-
neiolide 6 as one of the metabolites, presumably formed by 5-
hydroxylation of scytalidin 16 (Scheme 2). In addition, two novel
compounds 20 and 21 were isolated (3.2 mg and 0.7 mg
respectively) and their structures elucidated by MS and exten-
sive NMR studies (Table S10 and Fig. S50–S63†). The 13C NMR
spectrum of compound 20 (C22H28O8 from HRMS) showed
downeld signals assigned to the twomaleic anhydrides, as well
as an additional signal at dC 205 ppm assigned to a ketone. The
1H-NMR showed characteristic AB signals assigned to the
hydroxymethylene. Based on this evidence, and combined with
further analysis of 2D NMR data, the new metabolite was
assigned as the ring cleaved alcohol 20. The spectral data of 21
was also in accord with a ring cleaved metabolite with a ketone
in the side chain, but in this case the primary alcohol was oxi-
dised to a carboxylic acid and one of the carbonyls of the
anhydride reduced to give a mixture of epimers (dC 96.9/
97.4 ppm, dH 6.19/6.23 ppm). Such reductions of anhydrides are
commonly observed in maleidride biosynthesis.14,56,57 We
propose that ketone 20 may be formed via cleavage of the 5,6-
diol 6 to give an intermediate 22, which would tautomerise to
generate ketone 20. Oxidation of the primary alcohol of 20 to
a carboxylic acid and selective reduction of the anhydride would
give 21. Such linear bis(maleic anhydride) structures are not
without precedent, for example the fungal metabolite cor-
dyanhydride A 23.58 However, 23 has previously been proposed
to arise via the linear coupling of two distinct maleic anhydride
monomers rather than via cleavage of a cyclic intermediate.15Chem. Sci.Based on the bioinformatic analysis of the BGCs and the
identication of deoxyscytalidin 17 as an intermediate to both
scytalidin 16 and zopellin 15, it is a reasonable inference that
the two biosynthetic pathways proceed in an identical manner
to 17, aer which they diverge. Hydroxylation at C-6 would
produce scytalidin whereas hydroxylation at C-5, ring contrac-
tion and hydroxylation of the side chain would produce
zopellin.
ScyL2, being the only unique catalytic protein encoded by the
scytalidin BGC, was identied as a likely candidate for catalys-
ing the nal step in the scytalidin biosynthetic pathway. This is
supported by a bioinformatic analysis identifying ScyL2 as
a likely a-ketoglutarate dependent hydroxylase (Table S2†),
which shares homology with enzymes known to catalyse
hydroxylations, such as MfR1 and MfR2 from the squalestatin
pathway,37 and RbtB and RbtG from the rubratoxin pathway12
(Fig. S8–S10†). To conrm this role, scyL2 knock-out strains of S.
album were generated. These strains did not produce scytalidin
16, but accumulated deoxyscytalidin 17 (Fig. 5f), conrming the
role of ScyL2.
Recent work by Shiina et al.25 on the zopellin pathway of Z.
curvata, using heterologous expression as well as in vitro assays,
has begun to elucidate the later stages of zopellin biosyn-
thesis. ZopK, which is equivalent to ZopL9 of the D. curvata BGC
reported here, was shown to catalyse the oxidative ring
contraction in the zopellin pathway to produce deoxyzopellin
24.25 This proceeds via the intermediate 19 (which we now know
to be 5-hydroxy-deoxyscytalidin) and is consistent with our
identication, via feeding studies, of 19 as an intermediate in
the zopellin pathway. In vitro assays using puried recombi-
nant ZopL9 gave results which are entirely consistent with the
ndings of Shiina et al.25 In the presence of a-ketoglutarate,
ZopL9 was capable of catalysing highly efficient hydroxylation
of deoxyscytalidin 17 to give 5-hydroxy-deoxyscytalidin 19
(Fig. S68†). A minor compound was also detected which was
puried and identied as deoxyzopellin 24. Repeating the
assays using 5-hydroxy-deoxyscytalidin 19 as the substrate also
gave rise to deoxyzopellin 24 (Fig. S68†), in accord with theThis journal is © The Royal Society of Chemistry 2020


























































































View Article Onlineproposal that ZopL9 is implicated in the ring contraction in the
zopellin pathway of D. curvata, by rst hydroxylating deoxy-
scytalidin to give 19, then catalysing the ring contraction to give
the octadride core.
Having identied 17, 19 and 24 as intermediates in the
zopellin pathway – through both feeding studies and in vitro
assays – an extract of wild-type D. curvata was re-analysed, which
revealed the presence of all three compounds as minor
metabolites (Fig. S25†). Taken together with the bioinformatic
analysis and the discovery that ScyL2 catalyses the nal step of
the scytalidin pathway, a branching biosynthetic route for the
production of deoxyscytalidin, scytalidin and zopellin can now
be proposed as shown in Scheme 3.
Intriguingly there is a homologue to ZopL9 (PhiK) encoded
by the phomoidride BGC (44.2% homology – Fig. S11†). The
structure of the phomoidrides, e.g. 5, suggests that multiple
oxidations must occur during their biosynthesis, but no ring
contraction of the nine-membered core occurs in this pathway,
and the role of PhiK has not yet been investigated.
Conclusions
This work categorically establishes the biosynthetic relationship
between the nonadride scytalidin 16 and the octadride zopellin
15, via the shared nonadride intermediate; deoxyscytalidin 17. In
both pathways, deoxyscytalidin is the substrate for aKG-
dependent dioxygenase enzymes. In the scytalidin pathway
ScyL2 catalyses a 6-hydroxylation of deoxyscytalidin to produce
scytalidin whereas in the zopellin pathway ZopL9 catalyses a 5-
hydroxylation of deoxyscytalidin and is implicated in a ring
contraction to produce the octadride core. Interestingly, when
cultures of D. curvata DzopPKS were fed with scytalidin, (pos-
sessing a 6-hydroxy group), 5-hydroxylation occurred to give
castaneiolide 6 and two novel ring-cleaved maleidrides 20 and 21
were produced. Genes encoding aKG-dependent enzymes have
been identied within a further three maleidride BGCs; namely
rbtB, rbtE, rbtG and rbtU of the rubratoxin cluster, and the
currently uncharacterised phiK of the phomoidride BGC and pvL5
of the cornexistin BGC. This highlights the important role these,
oen multifunctional, enzymes play in generating the structural
diversity seen in the maleidride class of natural products.
Intriguing questions which remain to be answered regarding the
biosynthesis of zopellin include the mechanism by which the
ring contraction occurs, and the identication of the enzyme
responsible for installing the hydroxyl group at C-100 of the side
chain of zopellin. ZopR4, which is uniquely encoded by the
zopellin BGC and predicted to be a FAD-dependent oxidore-
ductase, is a candidate for catalysing such a transformation, but
this remains to be explored experimentally. Additionally, the
roles of the isochorismatase-like enzyme (ZopL2/ScyR4), the
enoyl CoA hydratase (ZopR2/ScyR2) and the small hypothetical
protein (ZopL8/ScyR11), which are encoded by both BGCs, are
currently unknown.
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